These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 415443

  • 41. Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography.
    Workman P, Little CJ, Marten TR, Dale AD, Ruane RJ, Flockhart IR, Bleehen NM.
    J Chromatogr; 1978 May 01; 145(3):507-12. PubMed ID: 659541
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. A comparison of the intracellular uptake and radiosensitization efficiency in different media of uncharged 2-nitroimidazoles of varying lipophilicity.
    Watts ME, Dennis MF, Jones NR, Stratford MR.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Sep 01; 52(3):359-70. PubMed ID: 3497892
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The pharmacokinetics of a new radiosensitiser, Ro 03-8799 in humans.
    Allen JG, Dische S, Lenox-Smith I, Malcolm SL, Saunders MI.
    Eur J Clin Pharmacol; 1984 Sep 01; 27(4):483-9. PubMed ID: 6519157
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. The reversible N-oxidation of the nitroimidazole radiosensitizer Ro 03-8799.
    Walton MI, Bleehen NM, Workman P.
    Biochem Pharmacol; 1985 Nov 01; 34(21):3939-40. PubMed ID: 4062968
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations.
    Saunders MI, Anderson PJ, Bennett MH, Dische S, Minchinton A, Stratford MR, Tothill M.
    Int J Radiat Oncol Biol Phys; 1984 Sep 01; 10(9):1759-63. PubMed ID: 6480459
    [Abstract] [Full Text] [Related]

  • 52. The role of dexamethasone in the modification of misonidazole pharmacokinetics.
    Jones DH, Bleehen NM, Workman P, Walton MI.
    Br J Cancer; 1983 Oct 01; 48(4):553-7. PubMed ID: 6626454
    [Abstract] [Full Text] [Related]

  • 53. The development of an oral prodrug, SR-2545, of the 2-nitroimidazole radiosensitizer SR-2508.
    Coleman CN, Lee WW, Constine LS, Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Oct 01; 8(3-4):431-4. PubMed ID: 6213588
    [Abstract] [Full Text] [Related]

  • 54. Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles.
    Hori H, Jin CZ, Kiyono M, Kasai S, Shimamura M, Inayama S.
    Bioorg Med Chem; 1997 Mar 01; 5(3):591-9. PubMed ID: 9113337
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Antiparasitic nitroimidazoles. 6. The metabolism and excretion of some 2-styryl-5-nitroimidazoles.
    Morton DM, Fuller DM, Green JN.
    Xenobiotica; 1973 Apr 01; 3(4):257-66. PubMed ID: 4749128
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Systemic, bladder wall, and bladder tumor concentration of misonidazole following intravesical administration in the rat.
    Fathi MA, Fisher GJ, Pageau R, Tahan TW, Nigam VN, Brailovsky CA, Elhilali MM.
    Int J Radiat Oncol Biol Phys; 1983 Sep 01; 9(9):1397-400. PubMed ID: 6885552
    [Abstract] [Full Text] [Related]

  • 60. A phase I study of the combined hypoxic cell radiosensitizers, Ro 03-8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations.
    Newman HF, Bleehen NM, Workman P.
    Br J Radiol; 1986 Apr 01; 59(700):423-5. PubMed ID: 2938660
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.